137 related articles for article (PubMed ID: 11936730)
21. Single- vs double-lumen central venous catheters in pediatric oncology patients.
Shulman RJ; Smith EO; Rahman S; Gardner P; Reed T; Mahoney D
Am J Dis Child; 1988 Aug; 142(8):893-5. PubMed ID: 3394681
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of quantitative blood cultures for the outcome of central venous catheters in children.
Germanakis J; Stiakaki E; Galanakis E; Christidou A; Neonakis J; Dimitriou H; Tselentis Y; Kalmanti M
Scand J Infect Dis; 2002; 34(9):680-2. PubMed ID: 12374360
[TBL] [Abstract][Full Text] [Related]
23. Prevention of coagulase-negative staphylococcal central venous catheter-related infection using urokinase rinses: a randomized double-blind controlled trial in patients with hematologic malignancies.
van Rooden CJ; Schippers EF; Guiot HF; Barge RM; Hovens MM; van der Meer FJ; Rosendaal FR; Huisman MV
J Clin Oncol; 2008 Jan; 26(3):428-33. PubMed ID: 18202420
[TBL] [Abstract][Full Text] [Related]
24. Central venous catheter clots: incidence, clinical significance and catheter care in patients with hematologic malignancies.
Barzaghi A; Dell'Orto M; Rovelli A; Rizzari C; Colombini A; Uderzo C
Pediatr Hematol Oncol; 1995; 12(3):243-50. PubMed ID: 7640177
[TBL] [Abstract][Full Text] [Related]
25. Risk factors for early infection of central venous catheters in pediatric patients.
Shaul DB; Scheer B; Rokhsar S; Jones VA; Chan LS; Boody BA; Malogolowkin MH; Mason WH
J Am Coll Surg; 1998 Jun; 186(6):654-8. PubMed ID: 9632153
[TBL] [Abstract][Full Text] [Related]
26. Alteplase versus urokinase in restoring blood flow in hemodialysis-catheter thrombosis.
Eyrich H; Walton T; Macon EJ; Howe A
Am J Health Syst Pharm; 2002 Aug; 59(15):1437-40. PubMed ID: 12166043
[TBL] [Abstract][Full Text] [Related]
27. Alteplase vs. urokinase for occluded hemodialysis catheter: A randomized trial.
Pollo V; DionÃzio D; Bucuvic EM; Castro JH; Ponce D
Hemodial Int; 2016 Jul; 20(3):378-84. PubMed ID: 26851872
[TBL] [Abstract][Full Text] [Related]
28. Thrombotic complications of central venous catheters in cancer patients.
Kuter DJ
Oncologist; 2004; 9(2):207-16. PubMed ID: 15047925
[TBL] [Abstract][Full Text] [Related]
29. Hydrochloric acid treatment of tunneled central venous catheter infections in children with cancer.
Larsen LN; Malchau E; Kristensen B; Schroeder H
J Pediatr Hematol Oncol; 2011 Mar; 33(2):e64-8. PubMed ID: 21285898
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of upper extremity deep venous thrombosis diagnosed by color Doppler duplex sonography in cancer patients with central venous catheters.
Gaitini D; Beck-Razi N; Haim N; Brenner B
J Ultrasound Med; 2006 Oct; 25(10):1297-303. PubMed ID: 16998102
[TBL] [Abstract][Full Text] [Related]
31. Use of urokinase in pediatric hematology/oncology patients.
Kellerman S; Chan J; Jarvis W
Am J Infect Control; 1998 Oct; 26(5):502-6. PubMed ID: 9795679
[TBL] [Abstract][Full Text] [Related]
32. A prospective randomized trial of urokinase as an adjuvant in the treatment of proven Hickman catheter sepsis.
Atkinson JB; Chamberlin K; Boody BA
J Pediatr Surg; 1998 May; 33(5):714-6. PubMed ID: 9607475
[TBL] [Abstract][Full Text] [Related]
33. A prospective randomized double-blind trial of bolus urokinase in the treatment of established Hickman catheter sepsis in children.
La Quaglia MP; Caldwell C; Lucas A; Corbally M; Heller G; Steinherz L; Brown AE; Groeger J; Exelby PR
J Pediatr Surg; 1994 Jun; 29(6):742-5. PubMed ID: 8078010
[TBL] [Abstract][Full Text] [Related]
34. Antibiotic and other lock treatments for tunnelled central venous catheter-related infections in children with cancer.
Schoot RA; van Dalen EC; van Ommen CH; van de Wetering MD
Cochrane Database Syst Rev; 2013 Jun; (6):CD008975. PubMed ID: 23799867
[TBL] [Abstract][Full Text] [Related]
35. Use of Tissue Plasminogen Activator as a Surrogate Measure for Central Venous Catheter Dysfunction and Survival Outcome in Children with Cancer: A Population-Based Retrospective Cohort Study.
Forbrigger Z; Kulkarni K
Pediatr Hematol Oncol; 2020 Oct; 37(7):554-560. PubMed ID: 32412356
[TBL] [Abstract][Full Text] [Related]
36. Recombinant tissue plasminogen activator in the treatment of central venous catheter occlusion in children.
Jacobs BR; Haygood M; Hingl J
J Pediatr; 2001 Oct; 139(4):593-6. PubMed ID: 11598611
[TBL] [Abstract][Full Text] [Related]
37. High-dose intradialytic urokinase to restore the patency of permanent central vein hemodialysis catheters.
Twardowski ZJ
Am J Kidney Dis; 1998 May; 31(5):841-7. PubMed ID: 9590195
[TBL] [Abstract][Full Text] [Related]
38. Successful Salvage of Central Venous Catheters in Patients with Catheter-Related or Central Line-Associated Bloodstream Infections by Using a Catheter Lock Solution Consisting of Minocycline, EDTA, and 25% Ethanol.
Raad I; Chaftari AM; Zakhour R; Jordan M; Al Hamal Z; Jiang Y; Yousif A; Garoge K; Mulanovich V; Viola GM; Kanj S; Pravinkumar E; Rosenblatt J; Hachem R
Antimicrob Agents Chemother; 2016 Jun; 60(6):3426-32. PubMed ID: 27001822
[TBL] [Abstract][Full Text] [Related]
39. Observational trial of antibiotic-coated central venous catheters in critically ill pediatric patients.
Chelliah A; Heydon KH; Zaoutis TE; Rettig SL; Dominguez TE; Lin R; Patil S; Feudtner C; St John KH; Bell LM; Coffin SE
Pediatr Infect Dis J; 2007 Sep; 26(9):816-20. PubMed ID: 17721377
[TBL] [Abstract][Full Text] [Related]
40. Developing a protocol to prevent and treat pediatric central venous catheter occlusions.
Harris JL; Maguire D
J Intraven Nurs; 1999; 22(4):194-8. PubMed ID: 10476135
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
